Yissum Technology Transfer Company of the Hebrew University

02/09/2026

🚀 Yissum Insight | H2 2026 is live

Innovation rarely begins with a licensing agreement. It usually begins with a conversation.

The path from discovery to application is built through excellent science, professional expertise, and the right connections.

In our latest issue, discover how Yissum | The Hebrew University Tech Transfer Company is strengthening that path - from intellectual property, licensing and startup creation to earlier engagement with industry, investors, entrepreneurs and international partners.

Inside: The Hebrew University of Jerusalem technologies open for collaboration in AI-powered biomedical prediction, cancer immunotherapy and sustainable agriculture; new platforms connecting research with industry; strategic partnerships extending the reach of Hebrew University innovation; and research moving toward application across health, agriculture, AI, synthetic biology and deep technology.

👉 Read Yissum Insight | H2 2026: https://lnkd.in/d4-PBNnZ

Looking for a technology, research expertise or a new collaboration opportunity? Let’s find the right path forward - together.

Yissum
Your Innovation. Our Journey. Shared Impact.

27/08/2026

🧬 What if programmable RNA could help the immune system see - and fight - cancer that has learned to hide from it?

That is the ambitious idea being advanced by ViVac Pharma, led by CEO Keren Leshem, who is featured on the cover of the August 2026 issue of Visionary Vogues in the story “The Visionary Turning Tomorrow’s Science into Hope for Millions.”

🔬 ViVac is developing next-generation RNA immunotherapies that combine synthetic biology with lipid nanoparticle delivery. Its platform is designed to deliver self-limiting, virus-like instructions directly into tumors, triggering a powerful but controlled localized immune response to help the body recognize and attack ovarian cancer and other solid tumors more effectively.

The company, built on pioneering research from The Hebrew University of Jerusalem laboratories of Prof. Lior Nissim and Prof. Chezy Barenholz, is currently at the preclinical proof-of-concept stage. ViVac reports validation in vitro and confirmation of RNA expression and tumor-targeted delivery in vivo as it works to advance its programs toward clinical development.

🚀 This progress is also reflected in ViVac’s recent selection to advance in the FY26 U.S. Department of Defense Ovarian Cancer Research Program, a highly competitive program supporting innovative research with the potential to improve outcomes for women with ovarian cancer.

As ViVac prepares for the program’s next phase, it is working alongside experienced ovarian cancer patient advocates so that patient perspectives can help shape the research from its earliest stages - bringing scientists, clinicians and patients together around the shared goal of developing better treatment options.

The cover story goes beyond the science. It follows Keren’s three-decade journey across biotechnology, pharmaceuticals, medical devices, diagnostics and women’s health - and explores the leadership required to turn breakthrough research into solutions that can ultimately reach patients.

💡 It highlights a philosophy built on purpose, resilience, collaboration and adaptability: remain committed to the mission, bring exceptional people together, and be willing to change the strategy as the evidence evolves.

👏 Warm Congratulations to Keren and the entire ViVac Pharma team on this well-deserved recognition. We are proud to see bold science originating at the Hebrew University being led forward with the ambition, experience and humanity required to pursue meaningful patient impact.

🔗 Read the full cover story: https://tinyurl.com/474sfcc7



The Hebrew University of Jerusalem ליאור ניסים

18/08/2026

🔬 If commercialization begins long before a technology is ready for market, where should the role of a technology transfer organization begin?

Alon Natanson, CEO of Yissum, and Gady Paran, Director of Marketing at Yissum, have published a new opinion piece in The Jerusalem Post, “The Next Evolution of Technology Transfer,” exploring the evolving role of technology transfer organizations in a changing innovation landscape.

As stated in the article, the core mission remains clear: intellectual property management, licensing and startup creation remain the foundation of technology transfer.

But commercialization often begins much earlier, through relationships, conversations and collaborations that can start long before a technology is ready for commercialization.

🤝 Drawing on Yissum’s experience over the past year, the article explores three complementary approaches: encouraging earlier dialogue between researchers and industry, strengthening collaboration between academic institutions, and bringing together the broader innovation community.

“Technology transfer organizations do not need a new mission. They need a broader view of how that mission succeeds.”

🌐 Looking further ahead, the article suggests:
“The organizations that create the greatest long-term impact may be those that also invest in something less tangible: the ecosystems that enable greater commercialization.”

➡️ Commercialization remains the destination. Building the conditions that allow more discoveries to reach that destination may become one of the defining responsibilities of technology transfer in the years ahead.

We hope the article contributes to the ongoing professional conversation about the future of technology transfer and how stronger connections across academia, industry, entrepreneurship and investment can help more discoveries move from research to impact.

📖 Read the full article in The Jerusalem Post:
https://tinyurl.com/yj8kjcnh

We invite you to read, share and continue the conversation with colleagues, partners and professional communities across the global innovation and technology transfer ecosystem.

Gady Paran The Hebrew University of Jerusalem

Today’s scientific breakthroughs rarely emerge in isolation. They are increasingly shaped by collaboration across disciplines, institutions, and sectors.

16/08/2026

🌍 #89 WORLDWIDE | Hebrew University of Jerusalem | Shanghai Ranking 2026

World-class research is where world-changing innovation begins.

The Hebrew University of Jerusalem has been ranked 89th among the world’s top 100 universities in the 2026 Shanghai Ranking (ARWU), reaffirming its place among the world’s leading academic and research institutions.

This year, two Israeli institutions are represented in the global top 100:
🇮🇱 Weizmann Institute of Science - #71
🇮🇱 The Hebrew University of Jerusalem - #89

Published annually since 2003, the Shanghai Ranking evaluates more than 2,500 universities worldwide, with a strong focus on research excellence and academic impact.

At Yissum | The Hebrew University Tech Transfer Company, we have the privilege of seeing where this research excellence can lead.

Every discovery holds the potential to become something more: a new technology, an industry collaboration, a startup, or a solution to a global challenge.

Today, we celebrate the researchers, faculty, students and entire Hebrew University community whose excellence makes achievements like this possible. Congratulations! 👏

As we look toward the 2026 - 2027 academic year, we look forward to the discoveries still to come, and to helping translate outstanding research into innovation and impact far beyond the university.



ShanghaiRanking Weizmann Institute of Science The Hebrew University of Jerusalem

13/08/2026

When innovation crosses borders, new opportunities begin 🇮🇱 🇹🇭

🌍 This week, Yissum | The Hebrew University Tech Transfer Company was pleased to welcome Mr. kraichok Arunpairojkul, Deputy Chief of Mission of the Royal Thai Embassy in Israel, to explore new connections between Thailand’s innovation ecosystem and the research, technologies and entrepreneurial activity of The Hebrew University of Jerusalem.

💡 The meeting offered an opportunity to exchange ideas and explore how Hebrew University research, technologies and startups can connect with Thailand’s industry, government, research and innovation communities.

🤝 At Yissum, we believe innovation thrives across borders. We are always happy to build new bridges with countries, governments, industries, investors and innovation ecosystems around the world, connecting outstanding research with shared challenges and opportunities for meaningful collaboration and impact.

🌏 Thank you, Mr. Arunpairojkul, for visiting Yissum. We look forward to continuing the dialogue and exploring opportunities to connect Thailand’s innovation ecosystem with the research, technologies and entrepreneurial activity of The Hebrew University of Jerusalem.

📸 Photo: At Yissum, from right: Alon Natanson, CEO of Yissum, and Mr. kraichok Arunpairojkul, Deputy Chief of Mission of the Royal Thai Embassy.

The Hebrew University of Jerusalem
Kraichok Arunpairojkul
Royal Thai Embassy, Tel Aviv (ทุกเรื่องเมืองยิว)

12/08/2026

🚀 Some jobs let you learn about innovation. This one puts you right where it begins.

We’re hiring at Yissum | The Hebrew University Tech Transfer Company!

Junior Business Development Manager – Exact Sciences and Social Sciences

About Yissum
Yissum is the technology transfer company of the Hebrew University of Jerusalem. We support academic research teams in building research collaborations with industry. We are seeking an organized, service-oriented professional for a role combining business development and coordination work.

Key Responsibilities
Manage a portfolio of researchers and technologies, documentation, and follow-up.
Serve as a responsive contact for researchers and external partners.
Support business development through research, analysis, and preparation of materials.
Coordinate industry collaborations, sponsored research, and innovation projects.
Support grant applications and related administrative submissions.
Maintain accurate records of technologies, contacts, meetings, and tasks.
Plan and administer events, visits, and delegations, including agendas, logistics, materials, and follow-up.

Qualifications
Academic degree in a scientific or technical field (e.g., Physics, Engineering, Chemistry, Computer Science, or a related discipline).
Excellent organizational, communication, and interpersonal skills.
Strong interest in science, technology, innovation, and entrepreneurship.
Ability to work independently, take initiative, and manage multiple tasks.
Fluent in Hebrew and English.
Familiarity with the Israeli innovation ecosystem, including startups, corporate innovation, and technology commercialization – an advantage.
Familiarity with industry sectors and innovation processes – an advantage.
Familiarity with Israel Innovation Authority (IIA) programs and other research and innovation funding schemes – an advantage.

Employment Terms
Position based at Yissum's offices, Givat Ram Campus, Jerusalem.
Hybrid: 4 times a week from the office, 1 day working from home.
Applications: [email protected]

Know someone who would be a great fit? Tag them or share this post.

Yissum.
Your Innovation. Our Journey. Shared Impact 💫

06/08/2026

🏙️ The next breakthrough in sustainable buildings may not be a new piece of equipment. It may be the paint already covering every wall.

Meet PureZone - a deep-tech innovation developed at The Hebrew University of Jerusalem that turns ordinary paint into an active, functional surface.

By integrating a proprietary additive into standard paint formulations, PureZone enables walls to:
🌿 Passively capture CO₂
💨 Neutralize harmful indoor volatile organic compounds (VOCs)
⚡ Operate without energy consumption
🏗️ Avoid complex hardware or changes to building operations

The technology’s strength lies not only in what it does, but in how readily it could be adopted.
🎨 Paint manufacturers could introduce high-value, climate-active products through existing production and distribution channels.
🏢 Building owners could transform existing surfaces into low-maintenance assets that support indoor-air-quality and sustainability goals.
🚀 Investors and strategic partners have an opportunity to participate in a scalable platform at the intersection of advanced materials, ClimateTech and the global building industry.

Developed by Dr. Uri Stoin and Prof. Yoel Sasson and supported by Yissum | The Hebrew University Tech Transfer Company, PureZone has successfully completed proof of concept and is now advancing toward industrial validation.

🤝 We are seeking paint manufacturers, building-industry partners and investors for strategic pilot collaborations and the technology’s next stage of development.

The walls are already there. PureZone makes them part of the solution.

Picture by Uri Stoin: Prof. Yoel Sasson (right) and Dr. Uri Stoin (left), the technology’s inventors.

www.purezone.site



Uri Stoin Anna Pellivert The Hebrew University of Jerusalem

31/07/2026

🔬 Every week, your intestine rebuilds itself. Scientists at The Hebrew University of Jerusalem have now uncovered one of the hidden cellular networks that helps make this extraordinary process possible.

The human intestine is one of the body's fastest-renewing organs, replacing almost its entire inner lining every 5-7 days while maintaining the delicate balance required for healthy function.

Now, a new study led by PhD student Amal Jerbi and Dr. Michal Shoshkes Carmel from the Department of Developmental Biology and Cancer Research at the Faculty of Medicine, The Hebrew University of Jerusalem, and published in Cellular and Molecular Gastroenterology and Hepatology, sheds new light on the remarkable cellular support system behind this process.

🧬 Using single-cell RNA sequencing and advanced spatial imaging, the research team discovered that specialized support cells known as telocytes do not form a single, uniform network. Instead, they are organized into four genetically distinct cell populations, each occupying a specific location along the intestine and delivering distinct molecular signals that help support intestinal stem cells and guide tissue renewal.

🔍 By combining molecular profiling with spatial mapping, the researchers generated a detailed atlas of the telocyte network, providing important new insight into how the intestine maintains the delicate balance between continuous regeneration and normal function.

💡 While the study was conducted in mice, it establishes an important foundation for future research into conditions in which this balance is disrupted, including inflammatory bowel disease, tissue injury, infections, aging, and colorectal cancer, while also providing a valuable framework for exploring whether similar mechanisms exist in humans.

👏 Congratulations to PhD student Amal Jerbi, Dr. Michal Shoshkes-Carmel and the entire research team on this outstanding achievement and on advancing our understanding of one of the body's most remarkable regenerative systems.

🌍 At Yissum | The Hebrew University Tech Transfer Company, we are proud to support pioneering discoveries from The Hebrew University of Jerusalem that expand the frontiers of human biology and help lay the foundations for tomorrow's medical innovations.

Read more: https://tinyurl.com/2r5pkaxp

Picture: Amal Jerbi

30/07/2026

Every breakthrough technology begins with a breakthrough question.

Today, we celebrate the researchers at The Hebrew University of Jerusalem whose curiosity, creativity, and scientific excellence have been recognized with prestigious Israel Science Foundation (ISF) grants.

Congratulations to the outstanding faculty members from the School of Computer Science and Engineering and the Institute of Applied Physics. Their research spans the frontiers of:
🔹 Artificial Intelligence
🔹 Cybersecurity & Network Security
🔹 Blockchain
🔹 Optimization
🔹 Computational Biology
🔹 Aerodynamics
🔹 Microphysiological Systems
🔹 Applied Physics

We are proud to congratulate faculty members from the School of Computer Science and Engineering:
👏 Prof. Aviv Zohar
👏 Prof. Gabriel Stanovsky
👏 Prof. Alex Samorodnitsky
👏 Dr. Alon Eden
👏 Prof. Yuval Kochman
👏 Prof. Tzvi Beatus
👏 Prof. Mor Arazi-Nizan
👏 Prof. Yaakov Nahmias, recipient of an ISF Breakthrough Research Program grant

Special congratulations also to the researchers from HUJI Applied Physics:
👏 Prof. Yossi Paltiel, recipient of an ISF MAPATZ Program grant for groundbreaking science
👏 Prof. Nir Bar-Gill
👏 Prof. Freddy Gabbay
👏 Prof. Amir Capua
👏 Prof. Yuri Feldman

Congratulations to all the award recipients on this well-deserved recognition. We look forward to seeing the impact of your next discoveries.



מדעי המחשב והנדסה - האוניברסיטה העברית Aviv Zohar Freddy Gabbay Amir Capua The Hebrew University of Jerusalem

21/07/2026

🏆 A breakthrough from The Hebrew University of Jerusalem is one step away from the global finals.

Out of more than 1,500 innovations from around the world, Cooling Crops has been selected as one of just 10 semi-finalists in the World Food Prize Foundation's Innovate for Impact Challenge. 🌍🌱

Developed at The Hebrew University of Jerusalem and commercialized by Yissum | The Hebrew University Tech Transfer Company, Cooling Crops is helping develop one of the most innovative solutions to protect crops from thermal stress and soil degradation, supporting a more resilient and sustainable future for agriculture.

Now it's our community's turn to help bring this breakthrough to the global stage.

We're inviting the entire Hebrew University community including researchers, students, alumni, faculty, staff, partners and friends to help Cooling Crops reach the finals.

💙 Public voting is now open, and every vote counts.

It takes less than a minute:

✅ Click the link below.
✅ Watch the short pitch.
✅ Vote for Cooling Crops.

👉 Vote here:
https://lnkd.in/dbA9TmCc

📅 Voting closes on July 25.

📣 Already voted? Please share this post and encourage your colleagues, fellow alumni, friends and family to vote as well. Every share helps us reach more supporters.

Let's show the world what the Hebrew University community can achieve when we come together.



Robert H Smith Faculty of Agriculture, Food and Environment, Rehovot The Hebrew University of Jerusalem